I'm looking
for help...
Aidpage is free!
   

Free downloads: GrantGate®  Federal Money Retriever®

PAUL CALABRESI AWARD FOR CLINICAL ONCOLOGY (K12)

Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
  • Original Grant - Apr 27, 2004
Applications Due:


Multiple Receipt Dates - See Link to Full Announcement for details.

total funding: Not Available
max award: none
min award: none
cost sharing, matching: No
number of awards: Not Available
type of funding: Grant
Description:

This PA announces the replacement of the NCI Institutional Clinical
Oncology Research Career Development (K12) Program (PAR-03-083 at
http://grants.nih.gov/grants/guide/pa-files/PAR-03-083.html) with the
Paul Calabresi Award for Clinical Oncology (K12) or PCACO. The
purpose of the PCACO is to increase the number of medical doctors
(M.D.'s, D.O.'s), and doctorally-degreed nurses (Ph.D.s or
equivalents) and basic scientists (Ph.D.s D.V.M.s, or equivalents)
who are highly-motivated and trained to: 1) perform clinical oncology
therapeutic research that develops and tests scientific hypotheses
based on fundamental and clinical research findings; 2) design and test
hypothesis-based, clinical therapeutic protocols and adjunct biological
analyses and for clinician candidates to administer all phases (i.e.,
pilot/Phase I, Phase II, and Phase III) of cancer therapeutic clinical
trials, and (3) conduct cancer therapeutic research in team research
settings in which basic and clinical scientists collaborate and
interact to expedite the translation of basic research discoveries into
patient-oriented therapeutic cancer research. The PCACO is not intended
to train laboratory-based scientists whose research will emphasize the
use of animal or other model systems.

For the purposes of this award, and in agreement with the
recommendations of the NIH Directors Panel on Clinical Research,
(http://www.nih.gov/news/crp/97report/index.htm), patient-oriented
research is defined as research conducted with human subjects (or on
material of human origin such as tissues, specimens and cognitive
phenomena) for which an investigator directly interacts with human
subjects. This area of research includes 1) mechanisms of human
disease; 2) therapeutic interventions; 3) clinical trials, and; 4) the
development of new technologies. Studies falling under Exemption 4 for
human subjects research are not included in this definition.

The NCI has named this award in honor of the late Dr. Paul Calabresi,
who was a pioneer in the pharmacological treatment of cancer and early
translational research. It recognizes him for his humanity, dedication
to his patients, mentorship of young clinical oncologists,
contributions to understanding and curing of cancer, untiring efforts
to promote and develop the field of clinical oncology, and ceaseless
service to the National Cancer Institute including his participation in
the strategic development of the Nations War on Cancer. Most of all,
this award is intended to symbolize the quality and excellence of the
physician scientists and the non-clinician translational researchers
that NCI hopes will become critical contributors to the future
elimination of death and suffering from cancer.

Individuals with medical degrees seeking a career development
experience exclusively in laboratory-based research should refer to the
NIH Mentored Clinical Scientist Career Development Award or K08 at the
following website: http://grants.nih.gov/grants/guide/pa-files/PA-00-003.html. Individuals with medical degrees interested in patient-
oriented research should refer to the NIH Mentored Patient-Oriented
Research Career Development Award or K23 at the following website:
http://grants.nih.gov/grants/guide/pa-files/PA-00-004.html.
Postdoctoral individuals (e.g., Ph.D.s) trained in laboratory-based
research, who wish to change direction and focus their research careers
on human cancer, should refer to the NCI Howard Temin Award or K01 at
the following website:
http://grants.nih.gov/grants/guide/pa-files/PAR-03-104.html.

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Cancer Research Manpower

More Information:

http://grants.nih.gov/grants/guide/pa-files/PAR-04-096.html

If you have problems accessing the full announcement, please contact: NIH OER Webmaster

Address Info:

SPONSORED LINKS
Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start